Stay updated on Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for a completed Phase 2 cabozantinib study in Japanese participants with advanced renal cell carcinoma is displayed, including its study design, eligibility criteria, outcomes, locations, publications, and study documents.SummaryDifference55%

- Check14 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH notice was added above the ClinicalTrials.gov navigation, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision marker changed from v3.7.1 to v3.7.2; the page still displays a 403 error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating access is blocked, instead of displaying the study record content. This blocks viewing the study details and navigation, and does not represent a substantive update to the page's information.SummaryDifference18%

Stay in the know with updates to Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Japanese Advanced Renal Cell Carcinoma Clinical Trial page.